| Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy (NCT01138202) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-11-01 |
| A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults (NCT01231516) | ViiV Healthcare | 2010-10-26 |
| PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV) (NCT01099579) | Bristol-Myers Squibb | 2010-10-13 |
| IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients (NCT00935480) | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 2010-10-01 |
| Telephone Support to Improve Adherence to Anti-HIV Medications (NCT00988442) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2010-10-01 |
| Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults (NCT01215149) | International AIDS Vaccine Initiative | 2010-10-01 |
| Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients (NCT01059422) | Central Institute of Epidemiology, Moscow, Russia | 2010-10-01 |
| A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects. (NCT01195974) | ViiV Healthcare | 2010-09-14 |
| Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol (NCT00639145) | Elizabeth Glaser Pediatric AIDS Foundation | 2010-09-01 |
| Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects (NCT01144026) | Thymon, LLC | 2010-09-01 |
| Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy (NCT01053325) | Institute of Tropical Medicine, Belgium | 2010-09-01 |
| R5 Integrase Study in HIV-1 Naive Patients (NCT01204905) | University of Maryland, Baltimore | 2010-09-01 |
| Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects (NCT01428596) | GeneCure Biotechnologies | 2010-09-01 |
| Reducing HIV in Adolescents (NCT01187979) | Centre for the AIDS Programme of Research in South Africa | 2010-09-01 |
| Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults (NCT01095224) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells (NCT01173510) | Community Research Initiative of New England | 2010-08-23 |
| Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users (NCT01105611) | St. James's Hospital, Ireland | 2010-08-01 |
| Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision (NCT01186575) | University of Washington | 2010-08-01 |
| Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users (NCT01161485) | University of Colorado, Denver | 2010-08-01 |
| Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects (NCT01066962) | ANRS, Emerging Infectious Diseases | 2010-08-01 |
| Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection (NCT01297127) | Hoffmann-La Roche | 2010-08-01 |
| A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH) (NCT01198418) | University of California, San Diego | 2010-07-09 |
| Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV (NCT01157442) | University of Manitoba | 2010-07-01 |
| Treatment Options for Protease Inhibitor-exposed Children (NCT01146873) | Columbia University | 2010-07-01 |
| Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men (NCT01087840) | Andrew Carr | 2010-07-01 |
| Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda (NCT01109342) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults (NCT01103687) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-07-01 |
| Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China (NCT01340950) | University of California, San Diego | 2010-07-01 |
| Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX (NCT01101815) | University of Pennsylvania | 2010-06-01 |
| A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings (NCT01150370) | Ministry of Health, Rwanda | 2010-06-01 |
| Metabolic and Psychological Changes Associated With Menopause Among Women With HIV (NCT01142817) | Massachusetts General Hospital | 2010-06-01 |
| Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam (NCT00651066) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-06-01 |
| Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon (NCT00658346) | ANRS, Emerging Infectious Diseases | 2010-06-01 |
| A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish] (NCT01013935) | New York University | 2010-06-01 |
| Treatment for Depression Among HIV-Infected Youth (NCT01049789) | University of North Carolina, Chapel Hill | 2010-06-01 |
| Brief Intervention for Drug Misuse in the Emergency Department (NCT01124591) | Rhode Island Hospital | 2010-06-01 |
| Mesalamine to Reduce T Cell Activation in HIV Infection (NCT01090102) | University of California, San Francisco | 2010-06-01 |
| PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers (NCT01108926) | St Stephens Aids Trust | 2010-06-01 |
| A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People (NCT01123915) | Medicines Development for Global Health | 2010-05-01 |
| Heart Function in HIV-Negative Children Exposed to HIV and HAART (NCT01107834) | Washington University School of Medicine | 2010-05-01 |
| Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 (NCT00993148) | Northwestern University | 2010-05-01 |
| The First Failure Study (NCT01118871) | Imperial College London | 2010-05-01 |
| Venue-Based Couples CoOp in South Africa (NCT01121692) | RTI International | 2010-05-01 |
| Eliciting Affect in Teens in a Virtual World (Project AVATAR) (NCT02338063) | Rhode Island Hospital | 2010-05-01 |
| Selective Exposure in HIV Prevention (NCT01152281) | University of Illinois at Urbana-Champaign | 2010-05-01 |
| Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru (NCT01118767) | Universidad Peruana Cayetano Heredia | 2010-05-01 |
| Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data (NCT01134939) | Boehringer Ingelheim | 2010-05-01 |
| High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals (NCT00885703) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-16 |
| Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix (NCT00946556) | University of Toronto | 2010-04-01 |
| Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients (NCT01190124) | Doroana, Maria Manuela, M.D. | 2010-04-01 |
| Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study (NCT01073761) | St Stephens Aids Trust | 2010-04-01 |
| A Safety Study of Dapivirine Vaginal Ring in Africa (NCT01071174) | International Partnership for Microbicides, Inc. | 2010-04-01 |
| Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults (NCT01106586) | Gilead Sciences | 2010-04-01 |
| Pharmacokinetics of Low Dose Raltegravir (NCT01159132) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-04-01 |
| Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults (NCT01108510) | Gilead Sciences | 2010-04-01 |
| Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study) (NCT01068873) | Temple University | 2010-04-01 |
| Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily (NCT01121809) | Hospitales Universitarios Virgen del Rocío | 2010-04-01 |
| A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring (NCT01144676) | International Partnership for Microbicides, Inc. | 2010-04-01 |
| Effect Of Maraviroc On The Pharmacokinetics Of Digoxin (NCT01056874) | ViiV Healthcare | 2010-03-01 |
| Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? (NCT00860977) | University Health Network, Toronto | 2010-03-01 |
| Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV (NCT00949234) | University of California, Los Angeles | 2010-03-01 |
| Stonewall Treatment Evaluation Project (NCT01129401) | University of California, San Francisco | 2010-03-01 |
| TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions (NCT01052883) | Tibotec Pharmaceuticals, Ireland | 2010-03-01 |
| Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation (NCT00872261) | FHI 360 | 2010-03-01 |
| TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients (NCT01090648) | Tibotec Pharmaceuticals, Ireland | 2010-03-01 |
| HIV Fat Redistribution and the Evaluation of Brown Fat (NCT01098045) | Massachusetts General Hospital | 2010-03-01 |
| Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM) (NCT01164462) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-03-01 |
| Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults (NCT01095796) | Gilead Sciences | 2010-03-01 |
| Pre-Exposure Prophylaxis Using TMC278LA (NCT01049932) | St Stephens Aids Trust | 2010-03-01 |
| Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine (NCT00962780) | Pfizer | 2010-03-01 |
| Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers (NCT01068925) | ViiV Healthcare | 2010-02-15 |
| Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children (NCT00802802) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-10 |
| Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults (NCT01260727) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-01 |
| Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program (NCT00947947) | University of North Carolina, Chapel Hill | 2010-02-01 |
| Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients (NCT01066065) | Hospital Carlos III, Madrid | 2010-02-01 |
| Sustiva Levels With Use of a Gel Capsule (NCT01087814) | University of Minnesota | 2010-02-01 |
| Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention (NCT01142882) | National Development and Research Institutes, Inc. | 2010-02-01 |
| Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV (NCT01002040) | University of British Columbia | 2010-02-01 |
| Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru (NCT01070017) | Brigham and Women's Hospital | 2010-02-01 |
| Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir (NCT01031849) | Ines Perez | 2010-02-01 |
| Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins (NCT01054872) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-01 |
| Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial (NCT00936195) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-01-01 |
| Durability of Adherence in Self-Management of HIV (NCT00991302) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2010-01-01 |
| Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels (NCT00987948) | University of Hawaii | 2010-01-01 |
| Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir (NCT01046890) | Germans Trias i Pujol Hospital | 2010-01-01 |
| TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278 (NCT01031589) | Tibotec Pharmaceuticals, Ireland | 2010-01-01 |
| Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test (NCT01032902) | Chembio Diagnostic Systems, Inc. | 2010-01-01 |
| Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults (NCT01029249) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2010-01-01 |
| Telephone Based Cognitive Behavioral Therapy for HIV Related Depression (NCT01055158) | University of Maryland, Baltimore | 2010-01-01 |
| Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria (NCT01044771) | Metropolis Medical | 2010-01-01 |
| An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons (NCT01059084) | University of Washington | 2010-01-01 |
| Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138) (NCT01048671) | Merck Sharp & Dohme LLC | 2010-01-01 |
| A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects (NCT01045369) | Therapeutic Concepts | 2010-01-01 |
| TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers (NCT01001247) | Tibotec Pharmaceuticals, Ireland | 2010-01-01 |
| Preventative Misconception Intervention (NCT01049139) | University of North Carolina, Chapel Hill | 2010-01-01 |
| Observational Study of Blood Treated With Cytolin (NCT01048372) | CytoDyn, Inc. | 2010-01-01 |
| A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761 (NCT01031472) | ViiV Healthcare | 2009-12-21 |
| Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women (NCT00993031) | University of California, San Francisco | 2009-12-15 |
| TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants (NCT00980538) | Janssen Sciences Ireland UC | 2009-12-09 |
| Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients (NCT00988780) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2009-12-01 |